AIDS and HIV Infection after Thirty Years.

Giuseppe Ippolito,Anders Sonnerborg,Jay A Levy,Ferdinand Mugusi,Ferdinando Dianzani

doi:10.1155/2013/731983

Abstract

AIDS and HIV Infection after Thirty Years.

Highlights

In the last 30 years since the recognition of the disease, clinicians, scientists, public health officials, policy makers, and volunteers have worked together to take care of people with Human Immunode ciency virus (HIV) infection, to identify new drugs and evaluate their efficacy, to better understand the virus and to assess its pathogenicity, to nd new tools to diagnose and prevent HIV infection, to assess the role of coinfections, and to mitigate the adverse events from antiretroviral treatment
Is large investment of resources has given impressive results and represents a welcomed scienti c success. As noted in this issue, a er 3 decades, Acquired Immunode ciency Syndrome (AIDS) has become at least for many industrialized countries a chronic disease affording patients a near-normal lifestyle and survival, if adequately treated [1, 2]. is year, United Nations Programme on HIV/AIDS (UNAIDS) reported an unprecedented acceleration in the clinical response to HIV/AIDS with more than a 50% reduction in the rate of new HIV infections even in some low- and middle-income countries
According to the abovementioned UNAIDS Global report, worldwide the number of people with access to antiretroviral therapy has increased by 63% in the last 24 months

Summary

Introduction

In the last 30 years since the recognition of the disease, clinicians, scientists, public health officials, policy makers, and volunteers have worked together to take care of people with HIV infection, to identify new drugs and evaluate their efficacy, to better understand the virus and to assess its pathogenicity, to nd new tools to diagnose and prevent HIV infection, to assess the role of coinfections, and to mitigate the adverse events from antiretroviral treatment. As noted in this issue, a er 3 decades, AIDS has become at least for many industrialized countries a chronic disease affording patients a near-normal lifestyle and survival, if adequately treated [1, 2]. The treatments for HIV/AIDS are very expensive and difficult to afford in resource-limited countries.

Results

Conclusion